Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Moderna Inc MRNA

Healthcare Biotechnology
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular... see more

Recent & Breaking News (NDAQ:MRNA)

David Meline Joins Moderna as Chief Financial Officer

Business Wire June 4, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA

GlobeNewswire June 3, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Announces Investigation into Moderna, Inc. (MRNA) for Possible Securities Fraud and Insider Trading, Encourages Investors with Significant Losses to Contact Firm

GlobeNewswire June 2, 2020

MRNA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Moderna, Inc. Investigation and Encourages Investors to Contact the Firm

PR Newswire June 2, 2020

Moderna Highlights Advances in Platform Science and Innovative Vaccine Research at Third Annual Science Day

Business Wire June 2, 2020

MODERNA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA

GlobeNewswire June 1, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Possible Securities Fraud and Insider Trading, Encourages Moderna, Inc. (MRNA) Investors with Significant Losses to Contact Firm

PR Newswire June 1, 2020

Stock Futures in Plus Category, Amid Hopes for 3rd Straight Monthly Gain

Livemoney June 1, 2020

Moderna Announces First Participants in Each Age Cohort Dosed in Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus

Business Wire May 29, 2020

Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity

PR Newswire May 28, 2020

CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna's Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2

Canada NewsWire May 28, 2020

MODERNA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA

GlobeNewswire May 27, 2020

Moderna, Inc. Investors: Company Investigated by the Portnoy Law Firm

GlobeNewswire May 27, 2020

CORRECTION and REPLACING - Shareholder Investigation: The Law Firm of Barbuto & Johansson, P.A. Investigates Moderna, Inc. (NasdaqGS: MRNA) After Vaccine Experts Lodge Criticism

GlobeNewswire May 27, 2020

FIRST FIRM TO INVESTIGATE NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Moderna, Inc. and Encourages Investors with Losses In Excess of $1,000,000 to Contact the Firm

ACCESSWIRE IA May 27, 2020

The Law Offices of Frank R. Cruz Continues Its Investigation on Behalf of Moderna, Inc. Investors (MRNA)

GlobeNewswire May 27, 2020

Shareholder Investigation: The Law Firm of Barbuto & Johansson, P.A. Investigates Moderna, Inc. (NasdaqGS: MRNA) After Vaccine Experts Lodge Criticism

GlobeNewswire May 27, 2020

Moderna to Present at Upcoming Investor Conferences

Business Wire May 27, 2020

MODERNA ALERT: Bragar Eagel & Squire, P.C. is Investigating Moderna, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm

Business Wire May 26, 2020

FIRST FIRM TO INVESTIGATE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Moderna, Inc. and Encourages Investors with Losses In Excess of $1,000,000 to Contact the Firm

ACCESSWIRE IA May 26, 2020